Ā | All | Falls (nā=ā133) | Non-falls (nā=ā496) | P-value |
---|---|---|---|---|
Baseline | ||||
āAge (years) | 68.7āĀ±ā12.4 | 73.8āĀ±ā (11.2) | 67.2āĀ±ā12.4 | ā<ā0.001 |
āSex (male/female) | 412/350 (65.5) | 331/298 (66.7) | 81/52 (60.9) | 0.483 |
āHeight (cm) | 161.1āĀ±ā11.4 | 159.4āĀ±ā9.8 | 161.9āĀ±ā9.2 | 0.006 |
āDW (kg) | 58āĀ±ā14.1 | 55.3āĀ±ā13.1 | 58.5āĀ±ā13.8 | 0.016 |
āBMI (kg/m2) | 21.9āĀ±ā3.9 | 21.6āĀ±ā3.9 | 22.1āĀ±ā3.9 | 0.197 |
Complications | ||||
āOrthopedic diseases (%) | 199 (31.6) | 66/133 (49.6) | 133/496 (26.8) | ā<ā0.001 |
āHeart diseases (%) | 260 (413) | 63/133 (47.4) | 196/496 (39.5) | 0.113 |
āCerebrovascular diseases (%) | 116 (18.4) | 39/133 (29.3) | 77/496 (15.5) | 0.001 |
āOrthostatic hypotension (%) | 127 (20.1) | 39/133 (29.3) | 88/496 (17.7) | 0.003 |
āEye diseases (%) | 191 (30.4) | 44/133 (33.1) | 147/496 (29.6) | 0.458 |
āParalysis (%) | 32 (5.1) | 16/133 (12) | 15/496 (3) | ā<ā0.001 |
āAmputation (%) | 26 (4.1) | 8/133 (6) | 18/496 (3.6) | 0.223 |
āDementia (%) | 102 (16.2) | 35/133 (26.3) | 68/496 (13.7) | 0.001 |
ESRD origin | ||||
āDiabetes mellitus (%) | 237 (37.6) | 48/133 (36.1) | 189/496 (38.1) | 0.688 |
āNephrosclerosis (%) | 162 (25.8) | 37/133 (27.8) | 125/496 (25.2) | 0.577 |
āChronic glomerulonephritis (%) | 57 (9) | 14/133 (10.5) | 43/496 (8.7) | 0.499 |
āPeripheral artery diseases (%) | 128 (20.3) | 30/133 (22.6) | 98/496 (19.8) | 0.469 |
Prescription | ||||
āAntiparkinsonian drugs (%) | 6 (0.9) | 3/133 (2.3) | 3/496 (0.6) | 0.112 |
āHypnotics (%) | 151 (24) | 42/133 (31.6) | 109/496 (22) | 0.029 |
āVasopressor drugs (%) | 133 (21.1) | 39/133 (29.3) | 94/496 (19) | 0.012 |
āAntihypertensive drugs (%) | 421 (66.9) | 89/133 (66.9) | 332/496 (66.9) | pā>ā0.99 |
āPsychotropic drugs (%) | 29 (4.6) | 6/133 (4.5) | 23/496 (4.6) | pā>ā0.99 |